Hemodynamics

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
1 program
1
Pico-SalaxPhase 41 trial
Active Trials
NCT00885430Completed20Est. Sep 2008
CH
Cardinal HealthOH - Dublin
1 program
Intermittent Pneumatic CompressionN/A1 trial
Active Trials
NCT05945186Unknown19Est. Nov 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ferring PharmaceuticalsPico-Salax
Cardinal HealthIntermittent Pneumatic Compression

Clinical Trials (2)

Total enrollment: 39 patients across 2 trials

Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes

Start: Jul 2008Est. completion: Sep 200820 patients
Phase 4Completed
NCT05945186Cardinal HealthIntermittent Pneumatic Compression

Design Validation Hemodynamic Study of New Kendall SCD SmartFlow Compression System

Start: Aug 2023Est. completion: Nov 202319 patients
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space